Evidence map›Paper›PMID 37227259›Full record

ArticleMicrobial genomics2023

Genomic surveillance of multidrug-resistant

Sophia David, Massimo Mentasti, Kirsty Sands, Edward Portal, Lee Graham, Joanne Watkins, Catie Williams, Brendan Healy, Owen B Spiller, David M Aanensen and 2 more

Abstract read
In one paragraph

Article in Microbial genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genomic surveillance of carbapenem-resistantFrontiers in microbiology · 2026
    Article
  5. Article
  6. Report of High-Risk Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sophia DavidCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford OX3 7LF, UK.
Massimo MentastiSpecialist Antimicrobial Chemotherapy Unit, Public Health Wales Microbiology, Cardiff CF14 4XW, UK.
Kirsty SandsDepartment of Zoology, University of Oxford, Oxford OX1 3SZ, UK.
Edward PortalDivision of Infection and Immunity, Cardiff University, Cardiff CF14 4XN, UK.
Lee GrahamPathogen Genomics Unit, Public Health Wales Microbiology, Cardiff CF14 4XW, UK.
Joanne WatkinsPathogen Genomics Unit, Public Health Wales Microbiology, Cardiff CF14 4XW, UK.
Catie WilliamsPathogen Genomics Unit, Public Health Wales Microbiology, Cardiff CF14 4XW, UK.
Brendan HealyPublic Health Wales Microbiology, Swansea SA2 8QA, UK.
Owen B SpillerDivision of Infection and Immunity, Cardiff University, Cardiff CF14 4XN, UK.
David M AanensenCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford OX3 7LF, UK.
Mandy WoottonSpecialist Antimicrobial Chemotherapy Unit, Public Health Wales Microbiology, Cardiff CF14 4XW, UK.
Lim JonesSpecialist Antimicrobial Chemotherapy Unit, Public Health Wales Microbiology, Cardiff CF14 4XW, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

KlebsiellaKlebsiella pneumoniaeGenomicsPlasmidsWalescarbapenemasecarbapenem resistancegenomic surveillanceKlebsiellapOXA-48-like plasmidsST307

Identifiers

PMID37227259
PMCPMC10272877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.